SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Piramal Enterprises gains on acquiring OTC brand ‘CALADRYL’ in India

01 Nov 2013 Evaluate

Piramal Enterprises is currently trading at Rs 566.10, up by 3.20 points or 0.57% from its previous closing of Rs 562.90 on the BSE.

The scrip opened at Rs 570.00 and has touched a high and low of Rs 572.05 and Rs 566.00 respectively. So far 1153 shares were traded on the counter.

The BSE group 'A' stock of face value Rs 2 has touched a 52 week high of Rs 648.30 on 02-Sep-2013 and a 52 week low of Rs 395.00 on 06-Nov-2012.

Last one week high and low of the scrip stood at Rs 586.00 and Rs 557.05 respectively. The current market cap of the company is Rs 9768.80 crore.

The promoters holding in the company stood at 52.97% while Institutions and Non-Institutions held 30.63% and 16.40% respectively.

Piramal Enterprises (formerly Piramal Healthcare) has acquired the over-the-counter (OTC) brand CALADRYL in India from Valeant Pharmaceuticals International, Inc. The brand CALADRYL in India was owned by Valeant Pharmaceuticals International, Inc (Valeant). The rights to this brand were acquired by Valeant from Johnson & Johnson in the year 2012. CALADRYL is an anti-pruritic solution known for dermatosis application for minor skin irritations and itching.

This acquisition enables the company to widen its consumer products portfolio in the skin care segment. Piramal Enterprises’ current consumer products portfolio includes brands such as Lacto Calamine, Saridon, i-Pill, Itchmosol and Supractiv Complete, along with niche market brands like Polycrol, i-Sure, i-Can, Jungle Magic, Tetmosol and Triactiv. The division has one of India’s largest field forces in the industry covering more than 100,000 towns.

Piramal Enterprises is one of India’s largest diversified companies, with a presence in pharmaceutical, financial services and information management sectors.

Piramal Ent - Amalga Share Price

1124.60 0.00 (0.00%)
22-Sep-2025 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×